Clinical trial Recruiting at 1 site Observational Ages 18 and up

Evaluating adherence to ESC guidelines for Chronic Coronary Syndrome

Official title: Chronic Coronary Syndrome Snapshot Study

Run by European Society of Cardiology · NCT06748924 · Data updated 2026-11-12

This study looks at how well doctors are following the latest guidelines for treating chronic coronary syndrome in adults to see what helps or hinders their care.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment4000 (estimated)
SponsorEuropean Society of Cardiology
Research network
Locations1 site (Yerevan)
StatusRecruiting
StartedDecember 2, 2024
Main results expectedJune 2, 2025
Study endsJune 2, 2025
Registry record updatedJanuary 9, 2025
Trial IDNCT06748924 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults with suspected coronary artery disease, new onset heart failure, or those within one year after an acute coronary syndrome.

Probably not a fit

Patients with a recent acute coronary syndrome or those with unrelated conditions that limit participation may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess how well healthcare professionals follow the 2019 European Society of Cardiology (ESC) Guidelines on Chronic Coronary Syndrome (CCS). It will evaluate adherence across various healthcare settings and identify barriers and facilitators to implementing these guidelines. The study will enroll adult patients with confirmed or suspected CCS to gather data on current practices and outcomes. The findings will help inform targeted interventions to improve guideline adherence and patient care.

Why it matters

Potential benefit: If successful, this study could enhance the quality of care for patients with Chronic Coronary Syndrome by improving adherence to established guidelines.

How similar studies have gone: Other studies have shown success in evaluating guideline adherence, making this approach both relevant and necessary.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with angina and/or dyspnoea, and suspected coronary artery disease.
* Patients with new onset of heart failure or reduced left ventricular function.
* Patients within 1 year after an acute coronary syndrome or recent revascularisation.
* Patients beyond 1 year after initial diagnosis or revascularisation.
* Patients with Angina with No Obstructive Coronary Artery disease (ANOCA)(e.g., microvascular angina, vasospastic angina).
* Asymptomatic subjects referred for screening for coronary artery disease.

Exclusion Criteria:

* Patients with a recent acute coronary syndrome (defined as those within 1 month of a diagnosis of unstable angina, non-ST-segment elevation myocardial infarction or ST-segment elevation myocardial infarction).
* Patients with conditions unrelated to CCS that significantly limit their ability to participate in the study or interfere with the assessment of guideline adherence.
* Patients participating in any clinical study where the protocol recommends deviations from guidelines recommendations.

Where it's running

  • Erebouni Medical Center
    Yerevan, Armenia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.